Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Genentech cut at least 489 jobs last year, new filing reveals
The layoff rounds are a collection of smaller cuts across departments and sites, and some involve broader changes at parent company Roche.
Darren Incorvaia
Feb 6, 2026 1:38pm
UniQure halts mid- to high-dosing for AAV gene therapy
Feb 6, 2026 10:56am
Sponsored
Inside Henlius’ global growth strategy
Feb 2, 2026 8:00am
Moderna CMO steps down in leadership mix-up—Chutes & Ladders
Feb 6, 2026 8:30am
Priovant will move brepocitinib to phase 3 after midstage win
Feb 6, 2026 7:00am
Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M
Feb 6, 2026 4:04am
More News
Fierce Biotech Layoff Tracker 2026: ARPA-H, GSK & more
Feb 5, 2026 2:55pm
Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease
Feb 5, 2026 12:15pm
Fierce Pharma
Astellas lifts forecast as Vyloy surge counters trial miss
Feb 5, 2026 11:00am
Angitia raises $130M to advance bone-building bispecifics
Feb 5, 2026 10:17am
See more stories